SCHEMBL1543593

SCHEMBL1543593

CC(C)C1=NC=C[N]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5601352 0.71
SCHEMBL6522863 0.64
SCHEMBL61745 0.58
SCHEMBL3937451 0.52
SCHEMBL2041196 0.52
SCHEMBL3655474 0.52
SCHEMBL11133489 0.50
SCHEMBL11802553 0.46 HRH4 (0.34)
SCHEMBL338867 0.44 GABRA1 (0.46)
SCHEMBL104124 0.44 TYR (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110306606-A1 NOVEL 2,6-SUBSTITUTED-3-NITROPYRIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME DONG WHA PHARM. CO., LTD. (KR) 2011-12-15 US claimed
EP-2394993-A2 NOVEL 2,6-SUBSTITUTED-3-NITROPYRIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME Dong Wha Pharm. Co., Ltd. (KR) 2011-12-14 EP claimed
US-7276567-B2 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-10-02 US claimed
US-20040006068-A1 Pyrimidine derivatives TULARIK INC. 2004-01-08 US claimed
EP-1056742-B1 ANTI-VIRAL PYRIMIDINE DERIVATIVES TULARIK INC (US) 2003-07-23 EP claimed
US-20030130264-A1 Methods of using pyrimidine-based antiviral agents TULARIK INC. (US) 2003-07-10 US claimed
US-6528513-B2 Viricides; especially cytomegalo virus TULARIK INC 2003-03-04 US claimed
US-20010018436-A1 Pyrimidine derivatives TULARIK INC. 2001-08-30 US claimed
US-6200977-B1 USEFUL IN TREATING AND SUPPRESSING HUMAN CYTOMEGALOVIRUS TULARIK INC. 2001-03-13 US claimed
US-4713457-A HYPOTENSIVE, ANTIULCER, ANTISECRETORY, ANTIDEPRESSANT, VASODILATING AGENTS MARUKO SEIYAKU CO., LTD. (JP) 1987-12-15 US claimed
US-20240109869-A1 CHARGE TRANSFER COMPLEX ADEKA CORPORATION (JP) 2024-04-04 US disclosed
EP-4289821-A1 CHARGE TRANSFER COMPLEX Adeka Corporation (JP) 2023-12-13 EP disclosed
CN-116710436-A Charge transfer complexes 株式会社艾迪科 2023-09-05 CN disclosed
CN-110191878-B Bicyclo [1.1.1] pentane inhibitors of dual leucine zipper (DLK) kinases for the treatment of diseases 德州大学系统董事会 2023-05-26 CN disclosed
US-20220194907-A1 PROCESS FOR THE PREPARATION OF MICROBIOCIDAL OXADIAZOLE DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2022-06-23 US disclosed
US-6200977-B1 USEFUL IN TREATING AND SUPPRESSING HUMAN CYTOMEGALOVIRUS TULARIK INC. 2001-03-13 US disclosed
US-4713457-A HYPOTENSIVE, ANTIULCER, ANTISECRETORY, ANTIDEPRESSANT, VASODILATING AGENTS MARUKO SEIYAKU CO., LTD. (JP) 1987-12-15 US disclosed
US-4399137-A 6-Imidazol-1-yl-3-hydrazino-pyridazines, their preparation and antihypertensive use BASF AKTIENGESELLSCHAFT (DE) 1983-08-16 US disclosed
EP-0026321-B1 6-IMIDAZOL-1-YL-3-HYDRAZINO-PYRIDAZINES, PROCESS FOR PREPARING THEM AND MEDICAMENTS CONTAINING THEM BASF Aktiengesellschaft (DE) 1983-02-09 EP disclosed
EP-0026321-A1 6-Imidazol-1-yl-3-hydrazino-pyridazines, process for preparing them and medicaments containing them BASF Aktiengesellschaft (DE) 1981-04-08 EP disclosed